Clinical Trial Update: Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing ivabradine to beta-blockers for inappropriate sinus tachycardia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inappropriate Sinus Tachycardia

Drugs mentioned

• IVABRADINE
• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Policlinico Casilino ASL RMB | Conditions: Inappropriate Sinus Tachycardia | Phase 3 | Status: COMPLETED